evertex fabrinology limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 148.2 million compared to TWD 144.69 million a year ago. Revenue was TWD 209.31 million compared to TWD 234.5 million a year ago. Net loss was TWD 6.06 million compared to net income of TWD 29.45 million a year ago. Basic loss per share from continuing operations was TWD 0.07 compared to basic earnings per share from continuing operations of TWD 0.34 a year ago. Diluted loss per share from continuing operations was TWD 0.07 compared to diluted earnings per share from continuing operations of TWD 0.34 a year ago. Basic loss per share was TWD 0.07 compared to basic earnings per share of TWD 0.34 a year ago. Diluted loss per share was TWD 0.07 compared to diluted earnings per share of TWD 0.34 a year ago.
For the six months, sales was TWD 382.6 million compared to TWD 266.64 million a year ago. Revenue was TWD 509.23 million compared to TWD 436.23 million a year ago. Net income was TWD 20.83 million compared to TWD 35.93 million a year ago. Basic earnings per share from continuing operations was TWD 0.24 compared to TWD 0.42 a year ago. Diluted earnings per share from continuing operations was TWD 0.24 compared to TWD 0.42 a year ago. Basic earnings per share was TWD 0.24 compared to TWD 0.42 a year ago. Diluted earnings per share was TWD 0.24 compared to TWD 0.42 a year ago.